Sermorelin benefits were narrow and measured in short studies
See which changes came from Sermorelin, which came from another drug, and what isn't proved.
Two short Sermorelin studies found the clearest benefits
Medicine called Sermorelin is designed to start a brief growth-hormone release. This page sorts the sermorelin benefits by the study behind each one. In older men, growth hormone and IGF-1, a later hormone made in your liver, rose toward younger men's levels [2]. Children who couldn't make enough growth hormone grew faster each year [1].
Tesamorelin is another medicine drawn from the same natural hormone, and it lasts longer in the bloodstream. In the study, it reduced body fat and slightly improved thinking-test scores in older adults [7]. Sermorelin can't claim those results. Most adult use against aging hasn't been approved, and long-term facts remain thin. A leading medical journal urged care [5].
Read each benefit as one study's finding. No finding can tell what will happen in your body.
Benefit 1: growth hormone and IGF-1 rose on blood tests
The best-proved sermorelin benefit is higher growth hormone plus IGF-1, which your liver makes. Healthy older men received 0.5 mg or 1 mg twice daily. After 14 days, their 24-hour growth-hormone reading climbed higher at the larger amount. IGF-1 also rose on a blood test. At the larger amount, both matched younger men's readings. Fasting blood sugar didn't change [2].
In another study, one amount kept growth hormone above its starting level for roughly three hours [3]. Sermorelin uses your gland instead of supplying growth hormone. The release can still slow, and the usual rise and fall remains [4].
The proved benefit is narrow: blood-test numbers moved. The studies didn't prove a change you could feel.
Benefit 2: Sermorelin leaves the body's controls at work
One medical article focused on how Sermorelin raises growth hormone. The drug gets your growth gland to make a brief burst. Direct growth-hormone shots add that hormone to your body. Because Sermorelin uses the gland, your normal controls and usual rise and fall remain [4].
The article argued that this may act more like your own hormone system. It didn't compare the two choices in a fair head-to-head study [4].
This might be a safety advantage. No direct study has shown better health or fewer harms.
Benefit 3: children lacking growth hormone grew faster
The clearest visible benefit came from children whose growth-hormone supply was low. With one Sermorelin shot each day, growth went from about 4.1 to roughly 7-8 cm/year. IGF-1, a later hormone made in your liver, didn't rise too high [1].
This childhood use once had drug approval. A ruler could show the change, so it wasn't only a blood-test result [1]. The finding can't establish a benefit for a healthy adult.
Benefit 4: tesamorelin changed body fat and thinking scores
People often hope for less body fat and clearer thought. The main study behind those hopes used tesamorelin, not Sermorelin. It followed 152 older adults for 20 weeks. They received 1 mg/day before bed. Body fat fell 7.4%. IGF-1, a later hormone made in your liver, rose 117%, yet ended within normal limits. A big percentage change can still finish inside those limits. The group gained a little on thinking tests, and side effects were mild [7].
Credit those gains to tesamorelin, where researchers measured them [7]. A separate review said IGF-1 might protect brain cells as people age [9]. That idea doesn't prove that Sermorelin improves memory.
The hopeful finding is real, but it belongs to a different drug.
No benefit study settles the long-term cancer concern
Most studies were short. Adult use against aging hasn't been approved. In 2008, a medical article judged the evidence too weak for anti-aging care [5].
Growth hormone and IGF-1, which your liver makes, help cells grow. If both stay high for years, doctors worry about cancer or other unwanted growth. Studies haven't shown that Sermorelin causes cancer. They also haven't settled that question [5].
A measured short-term change can be real while the long-term adult result remains unknown.